Time to HAART initiation after diagnosis and treatment of opportunistic infections in patients with AIDS in Latin America

dc.creatorCrabtree-Ramírez, Brenda
dc.creatorCaro-Vega, Yanink
dc.creatorShepherd, Bryan E
dc.creatorGrinsztejn, Beatriz
dc.creatorWolff, Marcelo
dc.creatorCortes, Claudia P
dc.creatorPadgett, Denis
dc.creatorCarriquiry, Gabriela
dc.creatorFink, Valeria
dc.creatorJayathilake, Karu
dc.creatorPerson, Anna K
dc.creatorMcGowan, Catherine
dc.creatorSierra-Madero, Juan
dc.creatorCCASAnet
dc.creatorIeDEA
dc.date2018-10-04T13:43:55Z
dc.date2018-10-04T13:43:55Z
dc.date2016
dc.date.accessioned2023-09-26T20:43:33Z
dc.date.available2023-09-26T20:43:33Z
dc.identifierCRABTREE-RAMÍREZ, Brenda. et al. Time to HAART Initiation after diagnosis and treatment of opportunistic infections in patients with AIDS in Latin America. PLoS ONE, v. 11, n. 6, p. e0153921, 2016.
dc.identifier1932-6203
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/29333
dc.identifier10.1371/journal.pone.0153921
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8862737
dc.descriptionCCASAnet- Caribbean, Central and South America Network for HIV Epidemiology;/ IeDEA- International Epidemiologic Databases to Evaluate AIDS Program.
dc.descriptionSince 2009, earlier initiation of highly active antiretroviral therapy (HAART) after an opportunistic infection (OI) has been recommended based on lower risks of death and AIDS-related progression found in clinical trials. Delay in HAART initiation after OIs may be an important barrier for successful outcomes in patients with advanced disease. Timing of HAART initiation after an OI in "real life" settings in Latin America has not been evaluated.
dc.formatapplication/pdf
dc.languageeng
dc.rightsopen access
dc.titleTime to HAART initiation after diagnosis and treatment of opportunistic infections in patients with AIDS in Latin America
dc.typeArticle


Este ítem pertenece a la siguiente institución